Pfizer Ordered to Give Moderna Key Covid Vaccine-Making Details (Correct)

Sept. 18, 2023, 7:31 PM UTCUpdated: Sept. 19, 2023, 1:50 PM UTC

Pfizer Inc. and BioNTech SE have until the end of the month to give ModernaTX Inc. key information on what it learned and when about critical details of Moderna’s mRNA vaccine formulation that helped rein in the coronavirus pandemic.

The judge’s order to turn over the information is the latest development in Moderna’s patent infringement suit against Pfizer and the German drug manufacturer, which have countersued. Moderna accuses them of infringing three patents covering its revolutionary mRNA vaccine technology used to create the Covid-19 vaccine. Both sides claim to have developed the technology.

Judge Richard G. Stearns on Friday gave ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.